Login / Signup
Hendrik Jürges
ORCID
Publication Activity (10 Years)
Years Active: 2019-2023
Publications (10 Years): 6
Top Topics
Cross Sectional
Phase Ii
Papillary Thyroid
Clinical Trial
Top Venues
BMJ (Clinical research ed.)
The European journal of health economics : HEPAC : health economics in prevention and care
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Thomas Michaeli
,
Hendrik Jürges
,
Daniel Tobias Michaeli
FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis.
BMJ (Clinical research ed.)
381 (2023)
Thomas Michaeli
,
Hendrik Jürges
,
Daniel Tobias Michaeli
FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis.
BMJ (Clinical research ed.)
381 (2023)
Thomas Michaeli
,
Hendrik Jürges
,
Daniel Tobias Michaeli
FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis.
BMJ (Clinical research ed.)
381 (2023)
Thomas Michaeli
,
Hendrik Jürges
,
Daniel Tobias Michaeli
FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis.
BMJ (Clinical research ed.)
381 (2023)
Tatjana Begerow
,
Hendrik Jürges
Does compulsory schooling affect health? Evidence from ambulatory claims data.
The European journal of health economics : HEPAC : health economics in prevention and care
(2021)
Hendrik Jürges
,
Sophie-Charlotte Meyer
Cognitive ability and teen smoking.
The European journal of health economics : HEPAC : health economics in prevention and care
21 (2) (2019)